These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 17159052

  • 1. Evaluation of the penetration of fluoroquinolones in human conjunctival tissue.
    Fiscella RG, Jensen MK.
    Arch Ophthalmol; 2006 Dec; 124(12):1796-7; author reply 1797. PubMed ID: 17159052
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of moxifloxacin, ciprofloxacin, gatifloxacin, ofloxacin, and levofloxacin concentrations in human conjunctival tissue.
    Wagner RS, Abelson MB, Shapiro A, Torkildsen G.
    Arch Ophthalmol; 2005 Sep; 123(9):1282-3. PubMed ID: 16157821
    [No Abstract] [Full Text] [Related]

  • 3. Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy.
    Shandil RK, Jayaram R, Kaur P, Gaonkar S, Suresh BL, Mahesh BN, Jayashree R, Nandi V, Bharath S, Balasubramanian V.
    Antimicrob Agents Chemother; 2007 Feb; 51(2):576-82. PubMed ID: 17145798
    [Abstract] [Full Text] [Related]

  • 4. Comparative intraocular penetration of 4 fluoroquinolones after topical instillation.
    Chung JL, Lim EH, Song SW, Kim BY, Lee JH, Mah FS, Seo KY.
    Cornea; 2013 Jul; 32(7):1046-51. PubMed ID: 23615274
    [Abstract] [Full Text] [Related]

  • 5. Aqueous humor penetration of fourth-generation fluoroquinolone ophthalmic solutions given by multiple administration in a rabbit model.
    Kobayakawa S, Ooki K, Tsuji A, Tochikubo T.
    J Infect Chemother; 2009 Aug; 15(4):209-13. PubMed ID: 19688238
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of subconjunctival injection of moxifloxacin in humans.
    Matsuura K.
    Graefes Arch Clin Exp Ophthalmol; 2013 Mar; 251(3):1019-20. PubMed ID: 22552573
    [No Abstract] [Full Text] [Related]

  • 7. Vitreous penetration of topical moxifloxacin and gatifloxacin in humans.
    Costello P, Bakri SJ, Beer PM, Singh RJ, Falk NS, Peters GB, Melendez JA.
    Retina; 2006 Feb; 26(2):191-5. PubMed ID: 16467677
    [Abstract] [Full Text] [Related]

  • 8. Penetration of moxifloxacin and levofloxacin into cancellous and cortical bone in patients undergoing total hip arthroplasty.
    Metallidis S, Topsis D, Nikolaidis J, Alexiadou E, Lazaraki G, Grovaris L, Theodoridou A, Nikolaidis P.
    J Chemother; 2007 Dec; 19(6):682-7. PubMed ID: 18230551
    [Abstract] [Full Text] [Related]

  • 9. Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty.
    Holland EJ, Lane SS, Kim T, Raizman M, Dunn S.
    Cornea; 2008 Apr; 27(3):314-9. PubMed ID: 18362660
    [Abstract] [Full Text] [Related]

  • 10. Conjunctival concentrations of a new ophthalmic solution formulation of moxifloxacin 0.5% in cataract surgery patients.
    Lindstrom R, Lane S, Cottingham A, Smith S, Sall K, Silverstein S, Shettle L, Walters T, Faulkner R, Cockrum P, Teuscher N.
    J Ocul Pharmacol Ther; 2010 Dec; 26(6):591-5. PubMed ID: 20925517
    [Abstract] [Full Text] [Related]

  • 11. Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model.
    Yağci R, Oflu Y, Dinçel A, Kaya E, Yağci S, Bayar B, Duman S, Bozkurt A.
    Eye (Lond); 2007 Jul; 21(7):990-4. PubMed ID: 16732216
    [Abstract] [Full Text] [Related]

  • 12. Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and moxifloxacin 0.5% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers.
    Torkildsen G, O'Brien TP.
    Clin Ther; 2008 Nov; 30(11):2005-14. PubMed ID: 19108788
    [Abstract] [Full Text] [Related]

  • 13. Phakic status affects vitreous penetration of topical moxifloxacin.
    Fuller JJ, McGwin G.
    Arch Ophthalmol; 2006 May; 124(5):749; author reply 749. PubMed ID: 16682605
    [No Abstract] [Full Text] [Related]

  • 14. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given in different concentrations in a wick before cataract surgery.
    Ong-Tone L.
    J Cataract Refract Surg; 2008 May; 34(5):819-22. PubMed ID: 18471639
    [Abstract] [Full Text] [Related]

  • 15. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans.
    McCulley JP, Caudle D, Aronowicz JD, Shine WE.
    Ophthalmology; 2006 Jun; 113(6):955-9. PubMed ID: 16603244
    [Abstract] [Full Text] [Related]

  • 16. Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans.
    Chang Lin JE, Welty D.
    Surv Ophthalmol; 2006 Jun; 51(5):530; author reply 530-1. PubMed ID: 16950254
    [No Abstract] [Full Text] [Related]

  • 17. Ocular penetration of moxifloxacin 0.5% and gatifloxacin 0.3% ophthalmic solutions into the aqueous humor following topical administration prior to routine cataract surgery.
    Kim DH, Stark WJ, O'Brien TP.
    Curr Med Res Opin; 2005 Jan; 21(1):93-4. PubMed ID: 15881479
    [Abstract] [Full Text] [Related]

  • 18. A comparison of fluoroquinolone penetration into human conjunctival tissue.
    Aihara M, Miyanaga M, Minami K, Miyata K, Eguchi S, Shiroma H, Sawaguchi S.
    J Ocul Pharmacol Ther; 2008 Dec; 24(6):587-91. PubMed ID: 19049265
    [Abstract] [Full Text] [Related]

  • 19. Relevance of aqueous humor concentrations of fluoroquinolones.
    Scassellati Sforzolini B, Sheets JW, Morris TW.
    J Cataract Refract Surg; 2011 Jan; 37(1):217-8. PubMed ID: 21183123
    [No Abstract] [Full Text] [Related]

  • 20. Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
    Caballero AR, Marquart ME, O'Callaghan RJ, Thibodeaux BA, Johnston KH, Dajcs JJ.
    Curr Eye Res; 2006 Jan; 31(1):23-9. PubMed ID: 16421016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.